Dana-Farber Cancer Institute’s Post

A new study published in NEJM AI sheds light on the integration of non-clinical AI technology into operations at Dana-Farber. With a focus on privacy, security, and compliance, a team led by Renato Umeton, Ph.D., and Jason Johnson, Ph.D., successfully implemented GPT4DFCI, an AI application designed to support various operational and research tasks within the institute. Read more about how Dana-Farber is paving the way for responsible AI adoption in healthcare: https://lnkd.in/eeeniTV9

It's intriguing to see how AI can support not just clinical tasks but also research and operations, potentially transforming patient care and internal processes. This approach could set a valuable precedent for AI's role in healthcare, balancing innovation with ethical considerations.

To view or add a comment, sign in

Explore topics